These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22101984)

  • 1. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes.
    Bouquet C; Melchers F
    Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.
    Hilbert DM; Theisen PW; Rudikoff EK; Bauer SR
    Oncogene; 1998 Oct; 17(16):2125-35. PubMed ID: 9798684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cDNA-library testing identifies transforming genes cooperating with c-myc in mouse pre-B cells.
    Wolf I; Bouquet C; Melchers F
    Eur J Immunol; 2016 Nov; 46(11):2555-2565. PubMed ID: 27538750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.
    Xu Z; Gwin KA; Li Y; Medina KL
    BMC Immunol; 2016 Jun; 17(1):16. PubMed ID: 27287229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
    Zippo A; De Robertis A; Serafini R; Oliviero S
    Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
    Feldman BJ; Reid TR; Cleary ML
    Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death.
    de Alborán IM; Baena E; Martinez-A C
    Cell Death Differ; 2004 Jan; 11(1):61-8. PubMed ID: 12970677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
    Smith DP; Bath ML; Harris AW; Cory S
    Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Vaux DL; Cory S; Adams JM
    Nature; 1988 Sep; 335(6189):440-2. PubMed ID: 3262202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated pim-1 and c-myc proto-oncogene induction in B lymphocytes from BLV-infected cows with persistent B lymphocytosis.
    Stone DM; Norton LK; Magnuson NS; Davis WC
    Leukemia; 1996 Oct; 10(10):1629-38. PubMed ID: 8847898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of precursor, immature, and mature murine B1-cell lines from c-myc/bcl-xL-overexpressing pre-BI cells.
    Wolf I; Bouquet C; Naumann F; Melchers F
    Eur J Immunol; 2017 May; 47(5):911-920. PubMed ID: 28294314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissues.
    Roh M; Kim J; Song C; Wills M; Abdulkadir SA
    Genesis; 2006 Oct; 44(10):447-53. PubMed ID: 17013838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.
    Langdon WY; Harris AW; Cory S
    Oncogene Res; 1988; 3(3):271-9. PubMed ID: 3144697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A; Harris AW; Bath ML; Cory S
    Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of IL-7 thresholds by SOCS proteins in developing B lineage cells.
    Corfe SA; Rottapel R; Paige CJ
    J Immunol; 2011 Oct; 187(7):3499-510. PubMed ID: 21873521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.